Allogeneic bone marrow transplantation for Pearson's syndrome.
Faraci
M
M
Cuzzubbo
D
D
Micalizzi
C
C
Lanino
E
E
Morreale
G
G
Dallorso
S
S
Castagnola
E
E
Schiaffino
M C
MC
Bruno
C
C
Rossi
A
A
Dini
G
G
Cappelli
B
B
D000935:Antifungal Agents / Q000008:administration & dosage; D000961:Antilymphocyte Serum; D000970:Antineoplastic Agents / Q000008:administration & dosage; D001229:Aspergillosis, Allergic Bronchopulmonary / Q000188:drug therapy / Q000209:etiology; D001483:Base Sequence / Q000235:genetics; D016026:Bone Marrow Transplantation; D004272:DNA, Mitochondrial / Q000235:genetics; D004579:Electron Transport / Q000235:genetics; D005260:Female; D030342:Genetic Diseases, Inborn / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D006086:Graft vs Host Disease / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D007223:Infant; D007951:Leukemia, Myeloid / Q000628:therapy; D008558:Melphalan / Q000008:administration & dosage; D028361:Mitochondrial Diseases / Q000150:complications / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D019653:Myeloablative Agonists / Q000008:administration & dosage; D017384:Sequence Deletion; D013577:Syndrome; D019172:Transplantation Conditioning; D014184:Transplantation, Homologous; D017211:Treatment Failure; D014740:Vidarabine / Q000031:analogs & derivatives
D000935:Antifungal Agents; D000961:Antilymphocyte Serum; D000970:Antineoplastic Agents; D004272:DNA, Mitochondrial; D007166:Immunosuppressive Agents; D019653:Myeloablative Agonists; D014740:Vidarabine; C024352:fludarabine; D008558:Melphalan